enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Belimumab - Wikipedia

    en.wikipedia.org/wiki/Belimumab

    Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), [6] also known as B-lymphocyte stimulator (BLyS). [7] It is approved in the United States [ 8 ] and Canada, [ 9 ] and the European Union [ 5 ] to treat systemic lupus erythematosus and lupus nephritis.

  3. Belantamab mafodotin - Wikipedia

    en.wikipedia.org/wiki/Belantamab_mafodotin

    Belantamab mafodotin, sold under the brand name Blenrep, is a monoclonal antibody conjugated with a cytotoxic agent for the treatment of relapsed and refractory multiple myeloma.

  4. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    Benlysta: mab: human: B-cell activating factor (BAFF) Y: systemic lupus erythematosus without renal or CNS involvement Bemarituzumab [26] mab: humanized: FGFR2: gastric cancer or gastroesophageal junction adenocarcinoma Benralizumab [38] Fasenra: mab: humanized: CD125: Y: asthma Berlimatoxumab [26] mab: human: Staphylococcus aureus bi-component ...

  5. Down 20%: Benylsta Not Ramping Fast Enough - AOL

    www.aol.com/news/2011-10-26-down-20-benylsta-not...

    Sales of Human Genome Sciences' (NAS: HGSI) new lupus drug Benylsta continues to grow -- just not fast enough to keep investors interest. The stock traded down more than 20% today after net sales ...

  6. Slow and Steady Has Investors Fleeing - AOL

    www.aol.com/2012/02/28/slow-and-steady-has...

    Slow and steady might win the race, but it isn't a way to keep biotech investors' interest. As we approach a year after GlaxoSmithKline (NYS: GSK) and Human Genome Sciences' (NAS: HGSI) Benlysta ...

  7. Lincoln Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Lincoln_Pharmaceuticals

    By the year 2000, the company's products were available in 80% of the domestic market across India. In 2010-11 the company launched three NDDS products. [7] In collaboration with Phafag AG, Switzerland, Lincoln Pharmaceuticals launched "Tinnex Injection" in India for Tinnitus disease. Tinnitus is commonly known as “bell ringing in the ear”. [8]

  8. Universal Immunisation Programme - Wikipedia

    en.wikipedia.org/wiki/Universal_Immunisation...

    Universal Immunisation Programme (UIP) is a vaccination programme launched by the Government of India in 1985. [1] It became a part of Child Survival and Safe Motherhood Programme in 1992 and is currently one of the key areas under the National Health Mission since 2005.

  9. Benlysta - Wikipedia

    en.wikipedia.org/?title=Benlysta&redirect=no

    From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).